Evidence map›Paper›PMID 41121146›Full record

ArticleBMC public health2025

National and subnational trends of years of life lost and reduced life expectancy caused by bladder cancer in China from 2005 to 2020.

Zhe Liu, Lingling Yu, Fanshu Yan, Jinlei Qi, Lijun Wang, Maigeng Zhou, Peng Yin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhe LiuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, Beijing, 100050, China.
Lingling YuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, Beijing, 100050, China.
Fanshu YanNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, Beijing, 100050, China.
Jinlei QiNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, Beijing, 100050, China.
Lijun WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, Beijing, 100050, China.
Maigeng ZhouNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, Beijing, 100050, China.
Peng YinNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, Beijing, 100050, China. yinpeng@ncncd.chinacdc.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBladder cancer was commonly diagnosed cancer, which has a high disease burden in China and the world. This study aims to better assess the epidemiological situation of bladder cancer in China.

methodsData for bladder cancer mortality were observed based on the data from the National Mortality Surveillance System. We analyzed the number of deaths, years of life lost(YLL), the age-standardized mortality rates(ASMR) and the age-standardized YLL rates due to bladder cancer in China during 2005-2020. We calculated the reduction in life expectancy due to bladder cancer.

resultsIn 2020, bladder cancer accounted for 29 730 deaths and 492 859 YLL in China. The ASMR and the age-standardized YLL rate of males were consistently higher than that of females. From 2005 to 2020, the reduction in life expectancy due to bladder cancer increased from 0.018 to 0.021 years. The reduction in life expectancy caused by bladder cancer in urban areas was consistently higher than that in rural areas, since this increased from 0.013 years in 2005 to 0.018 years in 2020 in rural areas. The reduction in life expectancy caused by bladder cancer in males was higher than that in females, and increased from 0.024 to 0.029 years in males between 2005 and 2020.

conclusionsThe number of deaths for bladder cancer in China has been increasing in recent years. Although the loss of life expectancy caused by bladder cancer in China was relatively small, the gradually increasing trend warrants attention, especially in economically developed regions.

Indexed as

Life ExpectancyUrinary Bladder NeoplasmsAdolescentAdultAgedAged, 80 and overChinaFemaleHumansMaleMiddle AgedYoung AdultBladder cancerLife expectancyReduction in life expectancyYears of life lost

Identifiers

PMID41121146
PMCPMC12542047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.